S. Giassas

发表

Second-line paclitaxel/carboplatin versus vinorelbine/carboplatin in patients who have advanced non-small-cell lung cancer pretreated with non-platinum-based chemotherapy: a multicenter randomized phase II study.

S. Agelaki, V. Georgoulias, K. Syrigos, 2011, Clinical lung cancer.

Short bowel syndrome after cytoreductive surgery and HIPEC: nutritional considerations.

J. Spiliotis, E. Halkia, S. Giassas, 2014, Journal of B.U.ON. : official journal of the Balkan Union of Oncology.

A phase II trial of erlotinib as front-line treatment in clinically selected patients with non-small-cell lung cancer.

V. Georgoulias, A. Voutsina, S. Agelaki, 2012, Clinical lung cancer.

Etoposide plus cisplatin followed by concurrent chemo-radiotherapy and irinotecan plus cisplatin for patients with limited-stage small cell lung cancer: A multicenter phase II study.

V. Georgoulias, A. Kalykaki, A. Polyzos, 2010, Lung cancer.

Paclitaxel in combination with carboplatin as salvage treatment in patients with castration-resistant prostate cancer: a Hellenic oncology research group multicenter phase II study

V. Georgoulias, A. Soultati, A. Kalykaki, 2012, Cancer Chemotherapy and Pharmacology.

Cytoreductive Surgery and HIPEC in Recurrent Epithelial Ovarian Cancer: A Prospective Randomized Phase III Study

J. Spiliotis, E. Halkia, S. Giassas, 2015, Annals of Surgical Oncology.

Α multicenter phase II study of pegylated liposomal doxorubicin in combination with irinotecan as second-line treatment of patients with refractory small-cell lung cancer

V. Georgoulias, G. Samonis, N. Ziras, 2011, Cancer Chemotherapy and Pharmacology.

Mapping the location of peritoneal metastases using the peritoneal cancer index and the correlation with overall survival: a retrospective study.

J. Spiliotis, P. Sugarbaker, E. Halkia, 2015, Journal of B.U.ON. : official journal of the Balkan Union of Oncology.

A phase II study of metronomic oral vinorelbine administered in the second line and beyond in non-small cell lung cancer (NSCLC): a phase II study of the Hellenic Oncology Research Group

V. Georgoulias, S. Agelaki, I. Varthalitis, 2013, Journal of chemotherapy.

Salvage treatment in metastatic breast cancer with weekly paclitaxel and bevacizumab

D. Mavroudis, V. Georgoulias, A. Kalykaki, 2011, Cancer Chemotherapy and Pharmacology.

Safety and Efficacy of RAD001 (Everolimus) Administered Upon Relapse During or After Adjuvant Treatment in Post-menopausal Women With Hormone Receptor Positive, HER2/neu Negative Locally Advanced or Metastatic Breast Cancer (CRAD001JGR08 “MELPOMENI” study)

C. Papadimitriou, I. Boukovinas, V. Michalaki, 2022, AntiCancer Research.

Second-line chemotherapy with Capecitabine (Xeloda) and Docetaxel (Taxotere) in previously treated, unresectable adenocarcinoma of pancreas: the final results of a phase II trial

D. Mavroudis, V. Georgoulias, A. Polyzos, 2011, Cancer Chemotherapy and Pharmacology.

Salvage Chemotherapy with Gemcitabine and Oxaliplatin in Heavily Pretreated Patients with Metastatic Breast Cancer: A Multicenter Phase II Study

V. Georgoulias, N. Malamos, D. Mavroudis, 2006, Oncology.

Oxaliplatin as First-Line Treatment in Inoperable Biliary Tract Carcinoma

V. Georgoulias, G. Aravantinos, K. Syrigos, 2006, Oncology.